Picture [iito] No Tracking 650x80px
Organisation › Details

EyeBrain (FR)

EyeBrain is developing brain function markers for neurological and psychiatric diseases utilizing devices based on eye motricity. They make it possible to test specific regions of the brain by recording and analyzing eye movements using very sophisticated algorithms developed by the company. The devices developed by EyeBrain have filled a void in the devices used in neurology; they complete a standard clinical examination within 20 minutes and at a lower cost than imaging techniques (MRI, scanners). They are also noninvasive relative to other types of examination in standard use (lumbar punctures, blood tests). The EyeBrain Tracker (EBT) devices come as a complete package that includes an eyetracker, a chin rest, two screens and a computer, together with stimulation and analysis software. When used routinely in hospital, they already provide the doctor with information for the early characterization of Parkinsonian syndromes (AMS, PSP, CBD, etc.), for monitoring multiple sclerosis and for dyslexia. The EBTs are the only devices of this type to have obtained CE marking, while EyeBrain also has ISO 9001 and ISO 13485 certification. Eye motricity testing (eye tracking) is paid for by the French social security system. EyeBrain, which was founded in 2008, is based in the Paris suburb of Ivry-sur-Seine and currently employs 12 people. The company raised 1.2 million euros from CapDecisif Management and G1JIDF in an initial funding round in 2009, and 3.3 million euros from Octalfa, Sudinnova and CM-CIC Capital Innovation in a second round in 2012. EyeBrain generates revenues from the sale of its tracker device. It is engaged in collaborations with the French National Institute of Health and Medical Research (Inserm), the French National Scientific Research Center (CNRS), the Paris Public Hospital Authority (AP-HP) and the University of Paris-Descartes. EyeBrain also has premises within the Brain and Spinal Cord Institute of the Pitié-Salpêtrière hospital in Paris, which is a world-class research center. *


Period Start 2008-01-01 established
Product Industry medical device
Person Person Kinkingnéhun, Serge (EyeBrain 201304 CEO)
Region Region Paris
  Country France
  Street 1 bis rue Jean le Galleu
  City 94200 Ivry-sur-Seine
  Tel +33-1-8364-3738
    Address record changed: 2020-12-02
Basic data Employees B: 11 to 50 (2012-10-08)
    * Document for �About Section�: EyeBrain. (4/11/13). "Press Release: EyeBrain Launches an International Clinical Trial of Its Application for Dyslexia. EUR 220,000 of Backing from the EUREKA-Eurostars Program". Ivry-sur-Seine.
Record changed: 2017-04-01


Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for EyeBrain (FR)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

» top